control subjects, but was increased relative to the cell density of surviving nigral cells
Studies show that NNMT inhibition by 5-amino-1-methylquinolinium significantly reduces nicotinamide metabolism, increases NAM accumulation, improves NAD+ synthesis efficiency by over 30%, and markedly increases mitochondrial ATP production and cellular energy metabolism
Purity: 99% (Peptide-Grade, HPLC Confirmed)
The optimal administration route in humans has not been definitively established through clinical trials
Furthermore, a sulforaphane intervention study in a cohort of healthy participants augmented peripheral and brain glutathione (Sedlak et al., 2017), an antioxidant readily implicated in various neurological functions (Dwivedi et al., 2020)
It is not intended for human or veterinary use, and must not be used for diagnostic, therapeutic, or clinical purposes